{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:07:42Z","timestamp":1789070862665,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA259260"],"award-info":[{"award-number":["R37CA259260"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["R35 CA304457"],"award-info":[{"award-number":["R35 CA304457"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["R01 CA283364"],"award-info":[{"award-number":["R01 CA283364"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["R01 HL128239"],"award-info":[{"award-number":["R01 HL128239"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["P50 CA254838-01"],"award-info":[{"award-number":["P50 CA254838-01"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029260","name":"West Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019368","name":"Applebaum Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ccell.2025.09.014","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:05:41Z","timestamp":1761235541000},"page":"203-220.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition"],"prefix":"10.1016","volume":"44","author":[{"given":"Eli L.","family":"Diamond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Emile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim I.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahan","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Bossert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya","family":"Petrova-Drus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine H.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Rotemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raajit K.","family":"Rampal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Daniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"R\u00f6sler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oshrat","family":"Hershkovitz-Rokah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roei D.","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Y.C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Adriana","family":"Cuibus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenyon","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Benbarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tittley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen-Aubart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Hanoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Schleinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Hautala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure Farnault","family":"De Lassus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6171","authenticated-orcid":false,"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.09.014_bib1","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S1470-2045(17)30031-1","article-title":"Histiocytoses: emerging neoplasia behind inflammation","volume":"18","author":"Haroche","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib3","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib4","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","article-title":"MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis","volume":"54","author":"Nelson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ccell.2025.09.014_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.09.014_bib7","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","article-title":"Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis","volume":"128","author":"Chakraborty","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib8","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","article-title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","volume":"123","author":"Nelson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib9","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2015-07-655530","article-title":"ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis","volume":"126","author":"Brown","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib11","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1182\/bloodadvances.2022009349","article-title":"Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms","volume":"7","author":"Durham","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ccell.2025.09.014_bib12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.revmed.2014.04.007","article-title":"[Erdheim-Chester disease]","volume":"35","author":"Haroche","year":"2014","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.ccell.2025.09.014_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000078","article-title":"Complete remission of critical neurohistiocytosis by vemurafenib","volume":"2","author":"Euskirchen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ccell.2025.09.014_bib15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3109\/0284186X.2015.1120885","article-title":"Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies","volume":"55","author":"Franconieri","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13104-015-1135-7","article-title":"Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report","volume":"8","author":"Tzoulis","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ccell.2025.09.014_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00256-016-2431-6","article-title":"Erdheim Chester disease with appendicular skeletal, renal and pleural involvement responding to Zelboraf (BRAF inhibitor) treatment: case report","volume":"45","author":"Borys","year":"2016","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.ccell.2025.09.014_bib18","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/IOP.0000000000000866","article-title":"Vemurafenib (BRAF Inhibitor) Therapy for Orbital Erdheim-Chester Disease","volume":"33","author":"Gupta","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ccell.2025.09.014_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/OTT.S121615","article-title":"Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease","volume":"10","author":"Varadi","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ccell.2025.09.014_bib20","series-title":"Detection of BRAF Mutations in Urine and Plasma Cell-free DNA: Application to the Diagnosis and Management of Histiocytic Disorder Patients","author":"Abdel-Wahab","year":"2014"},{"key":"10.1016\/j.ccell.2025.09.014_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2016-09-740217","article-title":"Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations","volume":"129","author":"Nordmann","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000299","article-title":"Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA","volume":"4","author":"Hunt","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.ccell.2025.09.014_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.09.014_bib24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/s41375-023-01947-4","article-title":"CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1\/2 inhibition","volume":"37","author":"Diamond","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2025.09.014_bib25","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1001\/jamaoncol.2022.4432","article-title":"Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status","volume":"8","author":"Abeykoon","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27237","article-title":"Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis","volume":"65","author":"Azorsa","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ccell.2025.09.014_bib27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.09.014_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/2159-8290.CD-15-0896","article-title":"Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.09.014_bib29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-17-1452","article-title":"Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties","volume":"8","author":"Gao","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.09.014_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/neuonc\/noab107","article-title":"Histiocytosis and the nervous system: from diagnosis to targeted therapies","volume":"23","author":"Cohen Aubart","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.09.014_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature23672","article-title":"A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease","volume":"549","author":"Mass","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.09.014_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713382","article-title":"S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy","volume":"24","author":"Razmkhah","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2025.09.014_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2020.11.004","article-title":"Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis","volume":"28","author":"Leimkuhler","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2025.09.014_bib35","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2024-203947","article-title":"Evaluation of the Lethal Activity and Its Mechanism of Tasquinimod in Advanced Myeloproliferative Neoplasm (MPN) in Blastic Phase","volume":"144","author":"Fiskus","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib36","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1158\/0008-5472.CAN-20-0865","article-title":"Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer","volume":"80","author":"Hanrahan","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.09.014_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1158\/2159-8290.CD-19-0356","article-title":"V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer","volume":"9","author":"Gao","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.09.014_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.09.014_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.ccell.2025.09.014_bib40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.09.014_bib41","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.09.014_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41592-024-02235-4","article-title":"Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis","volume":"21","author":"Hou","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.09.014_bib43","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2025.09.014_bib44","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ccell.2025.09.014_bib45","series-title":"ggplot2: Elegant Graphics for Data Analysis (3e)","author":"Hadley Wickham","year":"2016"},{"key":"10.1016\/j.ccell.2025.09.014_bib46","article-title":"Generating publication ready visualizations for Single Cell transcriptomics using SCpubr","volume":"2022","author":"Blanco-Carmona","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2025.09.014_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/neuonc\/noaa008","article-title":"Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series","volume":"22","author":"Bhatia","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00259-020-05047-8","article-title":"(18)F-FDG PET\/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study","volume":"48","author":"Kirchner","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ccell.2025.09.014_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.14997","article-title":"Efficacy of biological agents in the treatment of Erdheim-Chester disease","volume":"183","author":"Goyal","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2025.09.014_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41408-017-0034-7","article-title":"Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2025.09.014_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.2019.219626","article-title":"Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease","volume":"105","author":"Goyal","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2025.09.014_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jamaoncol.2017.0041","article-title":"Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease","volume":"3","author":"Goyal","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2025.09.014_bib53","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1002\/ajh.26119","article-title":"Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis","volume":"96","author":"Goyal","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ccell.2025.09.014_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ccell.2025.09.014_bib55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","article-title":"Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.09.014_bib56","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","article-title":"Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS","volume":"12","author":"Rose Brannon","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.09.014_bib57","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.09.014_bib58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2012.10.007","article-title":"An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia","volume":"22","author":"Gruber","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.09.014_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825004064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825004064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:49:43Z","timestamp":1773280183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825004064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1535610825004064"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.09.014","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}